Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03
Thursday, April 15 2021 | 09 h 33 min | Dry Eye, News, Press Release
Bausch + Lomb and Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, announced statistically significant...
Read More
Gene Therapy Approach to Regenerate Damaged Optic Nerves
Wednesday, April 14 2021 | 07 h 26 min | Vision Science
Scientists from the University of Cambridge have used gene therapy to regenerate damaged optic nerves in the eyes of mice, offering hope that this...
Read More
Using CRISPR to Treat Glaucoma
Wednesday, March 17 2021 | 08 h 12 min | Vision Science
Researchers from the University of Bristol that are looking for a more long-term treatment option for open angle glaucoma, have turned to gene...
Read More
CRISPR: Making the Cut to Restore Vision
Wednesday, March 3 2021 | 11 h 02 min | Vision Science
CRISPR (also known as CRISPR-Cas9) is a gene editing technique that allows scientists to cut DNA very precisely It’s like a pair of molecular...
Read More
LHON Study Finds Double the Impact
Wednesday, January 13 2021 | 10 h 58 min | Vision Science
In a surprising finding, scientists have shown that injecting a gene therapy for Leber’s Hereditary Optic Neuropathy (LHON) into one eye can...
Read More
